… Genetic polymorphisms of ABCB1 can lead to variations in P-… an influence of CYP2C19 and
CYP2B6, but not of ABCB1 38… Pharmacokinetics, pharmacodynamics and tolerability might …

… Our aim was to evaluate the effect of genetic polymorphisms in … on agomelatine
pharmacokinetics and pharmacodynamics. … of CYP2C9, CYP2C19 and ABCB1 among races …

… the effect of genetic polymorphisms of ABCB1 and the … group, CYP2C19*2, CYP3A4*1G,
and ABCB1 C3435T TT genotypes … impact of ABCB1, CYP2C19, CYP3A4, and CYP1A2 gene …

… in this article as follows: ABCB1 C3435T, ABCB1 C>T, rs4148738 for P-glycoprotein; … 3
(A6986G, rs776746) can affect clopidogrel pharmacokinetics and pharmacodynamics [18] in both …

… DPWG on using the ABCB1*6 C3435T polymorphism for personalizing therapy for patients,
but there has been research devoted to the influence of this SNP on the pharmacokinetics of …

… time that common genetic variants of ABCB1 (C3435T) and … to investigate the effects of
CYP2C19 polymorphisms on the … on the pharmacokinetics and pharmacodynamics of edoxaban …

… the impact of C3435T SNP of the ABCB1 gene on … genetic markers such as CYP2C19*3,
CYP2C19*17, CYP2C9*3 and PON1 Q192R proven to affect clopidogrels’ pharmacokinetics, …

… Because genetic polymorphism of CYP2C19 and ABCB1 3435 C>T are associated with
pharmacokinetics/pharmacodynamics of … CYP2C19*2/ABCB1-C3435T polymorphism and risk of …

… Eslicarbazepine shows an elimination half-life (t 1/2 ) of … is a weak CYP3A4 inducer and
CYP2C19 inhibitor. It undergoes … and safety; pharmacokinetics, pharmacodynamics, and …

… associated with ABCB1 and CYP2C19 genetic polymorphisms. … of CYP2C19 LOF and
GOF alleles and ABCB1 C3435T … on the clustering of CYP2C19 and ABCB1 genetic variants. …